Hydrocortisone Butyrate Lotion Recalled for cGMP Deviations
Teligent Pharma is recalling Hydrocortisone Butyrate Lotion 0.1% due to current Good Manufacturing Practice (cGMP) deviations related to the firm's discontinuation of its stability study program.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing practice deviation. The source text contains no reports of illness, injury, or product failure; the hazard is procedural and precautionary in nature rather than acute. Per the rubric, Class II recalls without reported adverse events typically fall in the Moderate range.
Plain-English summary
Teligent Pharma, Inc. is recalling all unexpired Hydrocortisone Butyrate Lotion, 0.1%, in 4 fl oz (118 mL) bottles (NDC 70512-032-04), manufactured for SOLA Pharmaceuticals. The recall includes batches 16896 and 16897, with an expiration date of 5/31/2023. Approximately 6874 bottles are affected.
The recall is being conducted because the firm is discontinuing its stability study program, which constitutes a deviation from current Good Manufacturing Practice (cGMP) standards. This results in a lack of adequate data to support the continued distribution of the product.
The affected product has been distributed nationwide in the United States and Puerto Rico. This is a prescription-only medication. Patients currently using this product should contact their healthcare provider for guidance before discontinuing use.
The recalled product
- Product
- Hydrocortisone Butyrate Lotion, 0.1%, 4 fl oz (118 mL) bottle, Rx only, Manufactured for: SOLA Pharmaceuticals, Baton Rouge, LA 70809, NDC 70512-032-04.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Corticosteroid
- Affected units
- 6,874
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 16896
- 16897 Exp. 5/31/2023
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · cgmp deviation
See all →- ModeratePritam International Recalls Brush Buddies Toothpaste Due to CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModerateARU Toothpaste Recalled for CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModeratePritam International Recalls Brush Buddies Fluoride Toothpaste for CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModeratePritam International Recalls Brush Buddies Toothpaste Due to CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModeratePritam International Recalls My Little Pony Toothpaste for CGMP Deviations
FDA (Drugs) · 2026-10-28
Similar recalls
- ModerateBetamethasone Dipropionate Lotion recalled for failed stability test
FDA (Drugs) · 2022-01-05
- LowQualitest Recalls Hydrocortisone Lotion for Excessive Potency
FDA (Drugs) · 2017-05-31
- HighHalobetasol Propionate Ointment 0.05% Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2022-05-11
- ModerateLidocaine Hydrochloride Topical Solution recalled for CGMP deviations
FDA (Drugs) · 2021-12-22
- ModerateValeant Recalls Subpotent Hydrocortisone Butyrate Cream 0.1% Tubes
FDA (Drugs) · 2014-10-22
- SevereSynergy Rx Recalls Hydrocortisone Cream Due to Sterility Assurance Issues
FDA (Drugs) · 2017-03-22